The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
Open accessAbstract
Cdc25 phosphatases activate cyclin-dependent kinases (Cdks) and thereby promote cell cycle progression. In vertebrates, Chk1 and Chk2 phosphorylate Cdc25A at multiple N-terminal sites and target it for rapid degradation in response to genotoxic stress. Here we show that Chk1, but not Chk2, phosphorylates Xenopus Cdc25A at a novel C-terminal site (Thr504) and inhibits it from C-terminally interacting with various Cdk-cyclin complexes, including Cdk1-cyclin A, Cdk1-cyclin B, and Cdk2-cyclin E. Strikingly, this inhibition, rather than degradation itself, of Cdc25A is essential for the Chk1-induced cell cycle arrest and the DNA replication checkpoint in early embryos. 14-3-3 proteins bind to Chk1-phosphorylated Thr504, but this binding is not required for the inhibitory effect of Thr504 phosphorylation. A C-terminal site presumably equivalent to Thr504 exists in all known Cdc25 family members from yeast to humans, and its phosphorylation by Chk1 (but not Chk2) can also inhibit all examined Cdc25 family members from C-terminally interacting with their Cdk-cyclin substrates. Thus, Chk1 but not Chk2 seems to inhibit virtually all Cdc25 phosphatases by a novel common mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chk1 then phosphorylates numerous downstream targets, including the Cdc25A phosphatase (Uto et al., 2004), which prompts Cdc25A proteasomal degradation (Mailand et al., 2000; Xiao et al., 2003).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Uto et al., 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Checkpoints: Controls That Ensure the Order of Cell Cycle Events
Hartwell, L. H., & Weinert, T. A. (1989) · Science · doi:10.1126/science.2683079 · Cited by 3,053
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
Barlow, C., Hirotsune, S., Paylor, R. E., Liyanage, M., Eckhaus, M., Collins, F. S., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80086-0 · Cited by 1,465
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
Cited by
Sorted by citations
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Roles of Chk1 in cell biology and cancer therapy
Zhang, Y., & Hunter, T. (2014) · International Journal of Cancer · doi:10.1002/ijc.28226 · Cited by 462
DNA damage checkpoints in mammals
Niida, H., & Nakanishi, M. (2005) · Mutagenesis · doi:10.1093/mutage/gei063 · Cited by 447
Checkpoint kinase 1 in DNA damage response and cell cycle regulation
Patil, M., Pabla, N., & Dong, Z. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1307-3 · Cited by 317
Cdc25: mechanisms of checkpoint inhibition and recovery
Karlsson, C., & Millar, J. B. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.002 · Cited by 288
Dual Roles for DNA Polymerase η in Homologous DNA Recombination and Translesion DNA Synthesis
Kawamoto, T., Araki, K., Sonoda, E., Yamashita, Y. M., Harada, K. H., Kikuchi, K., Masutani, C., Hanaoka, F., Nozaki, K., Hashimoto, N., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.016 · Cited by 231
The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis
Shen, T., & Huang, S. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012800617678 · Cited by 241
The DNA damage response: sensing and signaling
McGowan, C. H., & Russell, P. R. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.005 · Cited by 204
From Egg to Gastrula: How the Cell Cycle Is Remodeled During the Drosophila Mid-Blastula Transition
Farrell, J. A., & O’Farrell, P. H. (2014) · Annual Review of Genetics · doi:10.1146/annurev-genet-111212-133531 · Cited by 186
Regulation of mitotic entry by microcephalin and its overlap with ATR signalling
Alderton, G. K., Galbiati, L., Griffith, E., Surinya, K. H., Neitzel, H., Jackson, A. P., Jeggo, P. A., & O’Driscoll, M. (2006) · Nature Cell Biology · doi:10.1038/ncb1431 · Cited by 168
Tse, A. N., Rendahl, K. G., Sheikh, T. N., Cheema, H., Aardalen, K., Embry, M. G., Ma, S., Moler, E. J., Ni, Z., de Menezes, D. E. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1424 · Cited by 145
Kanemori, Y., Uto, K., & Sagata, N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501873102 · Cited by 128
Self-citationMitotic phosphatases: no longer silent partners
Trinkle‐Mulcahy, L., & Lamond, A. I. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.09.001 · Cited by 119
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114
“These include the tumor suppressors PTEN (Song et al., 2008a), NOTCH1 (Shan et al., 2018), the Foxo proteins (van der Horst et al., 2006) Frontiers in Cell and Developmental Biology | www.frontiersin.org 14 August 2020 | Volume 8 | Article 717 and the retinoblastoma protein (Bhattacharya and Ghosh,…”
BackgroundLi, L., & Zou, L. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20355 · Cited by 117
CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage
Schmitt, E., Boutros, R., Froment, C., Monsarrat, B., Ducommun, B., & Dozier, C. (2006) · Journal of Cell Science · doi:10.1242/jcs.03200 · Cited by 107
Regulation of the cellular DNA double-strand break response
Cann, K. L., & Hicks, G. G. (2007) · Biochemistry and Cell Biology · doi:10.1139/o07-135 · Cited by 105
Laezza, C., Pisanti, S., Crescenzi, E., & Bifulco, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.074 · Cited by 99
Brenner, A. K., Reikvam, H., Lavecchia, A., & Bruserud, Ø. (2014) · Molecules · doi:10.3390/molecules191118414 · Cited by 91
Lant, B., & Storey, K. B. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.9 · Cited by 88
The Polo‐like kinase Plx1 interacts with and inhibits Myt1 after fertilization of Xenopus eggs
Inoue, D., & Sagata, N. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600567 · Cited by 79
DNA replication and mitotic entry: A brake model for cell cycle progression
Lemmens, B. B. L. G., & Lindqvist, A. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201909032 · Cited by 75
Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic
Priya, B., Ravi, S., & Kirubakaran, S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103662 · Cited by 77
Development of Synthetic Lethality Anticancer Therapeutics
Fang, B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500415t · Cited by 73
Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase
Okamoto, K., & Sagata, N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607357104 · Cited by 70
Tewari‐Singh, N., Gu, M., Agarwal, C., White, C. W., & Agarwal, R. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100038b · Cited by 69
Endocannabinoids in endocrine and related tumours
Bifulco, M., Malfitano, A. M., Pisanti, S., & Laezza, C. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0258 · Cited by 64
Centrosomes in the DNA damage response—the hub outside the centre
Mullee, L. I., & Morrison, C. G. (2015) · Chromosome Research · doi:10.1007/s10577-015-9503-7 · Cited by 63
Investigational CHK1 inhibitors in early phase clinical trials for the treatment of cancer
Dent, P. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1694661 · Cited by 58
Chung, T.-W., Lin, S., Su, J., Chen, Y., Lin, C., & Chan, H. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1583-9 · Cited by 58
Redundant pathways for Cdc2 activation in Xenopus oocyte: either cyclin B or Mos synthesis
Haccard, O., & Jessus, C. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400611 · Cited by 57
CDC25B Phosphorylation by p38 and MK-2
Lemaire, M., Froment, C., Boutros, R., Mondésert, O., Nebreda, Á. R., Monsarrat, B., & Ducommun, B. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3006 · Cited by 54
Sankunny, M., Parikh, R. A., Lewis, D. W., Gooding, W. E., Saunders, W. S., & Gollin, S. M. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22125 · Cited by 56
Cdc25 and the importance of G2control
Kimelman, D. (2014) · Cell Cycle · doi:10.4161/cc.29537 · Cited by 48
On the Interplay of the DNA Replication Program and the Intra-S Phase Checkpoint Pathway
Ciardo, D., Goldar, A., & Marheineke, K. (2019) · Genes · doi:10.3390/genes10020094 · Cited by 47
G2 acquisition by transcription-independent mechanism at the zebrafish midblastula transition
Nogare, D. E. D., Pauerstein, P. T., & Lane, M. E. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.11.002 · Cited by 45
Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 55
Wang, F.-Z., Fei, H., Cui, Y., Sun, Y., Li, Z.-M., Wang, X., Yang, X., Zhang, J.-G., & Sun, B. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1010-3 · Cited by 47
Zhang, R., Shi, H., Ren, F., Zhang, M., Ji, P., Wang, W., & Liu, C. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0356-x · Cited by 46
DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2
Bourke, E., Brown, J. A. L., Takeda, S., Hochegger, H., & Morrison, C. G. (2009) · Oncogene · doi:10.1038/onc.2009.340 · Cited by 44
Isoda, M., Kanemori, Y., Nakajo, N., Uchida, S., Yamashita, K., Ueno, H., & Sagata, N. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0008 · Cited by 42
Ohe, M., Kawamura, Y., Ueno, H., Inoue, D., Kanemori, Y., Senoo, C., Isoda, M., Nakajo, N., & Sagata, N. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-11-0974 · Cited by 40
Collart, C., Smith, J. C., & Zegerman, P. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.06.010 · Cited by 38
Cell cycle control during early embryogenesis
Brantley, S. E., & Talia, S. D. (2021) · Development · doi:10.1242/dev.193128 · Cited by 40
Shi, L., Li, M., Lin, Q., Qi, X., & Su, B. (2013) · BMC Biology · doi:10.1186/1741-7007-11-62 · Cited by 40
Tong, Y., Claiborne, A. K., Stewart, K. D., Park, C., Kovar, P. J., Chen, Z., Credo, R. B., Gu, W., Gwaltney, S. L., Judge, R. A., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.012 · Cited by 39
MAPK Pathway Activation Delays G2/M Progression by Destabilizing Cdc25B
Astuti, P., Soliman, T. N., Widberg, C., Payne, E., Harding, A. S., Hancock, J. F., & Gabrielli, B. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027516 · Cited by 37
The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target
Alao, J. P. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902835475 · Cited by 36
Uchida, S., Yoshioka, K., Kizu, R., Nakagama, H., Matsunaga, T., Ishizaka, Y., Poon, R. Y. C., & Yamashita, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0869 · Cited by 36
Shindo, Y., & Amodeo, A. A. (2021) · Current Biology · doi:10.1016/j.cub.2021.03.035 · Cited by 32
Chk1 versus Cdc25: Chking One’s Levels of Cellular Proliferation
Lam, M. H., & Rosen, J. M. (2004) · Cell Cycle · doi:10.4161/cc.3.11.1225 · Cited by 33
Jeon, Y., Lee, K. Y., Ko, M. J., Lee, Y. S., Kang, S., & Hwang, D. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609116200 · Cited by 34
Ling, H. Y., Wen, L., Ji, X., Tang, Y., He, J., Tan, H., Xia, H.-Q., Zhou, J., & Su, Q. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500004 · Cited by 33
Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A
Shen, T., Shang, C., Zhou, H., Luo, Y., Barzegar, M., Odaka, Y., Wu, Y., & Huang, S. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.135 · Cited by 31
Chk1 phosphorylates the tumour suppressor Mig‐6, regulating the activation of EGF signalling
Liu, N., Matsumoto, M., Kitagawa, K., Kotake, Y., Suzuki, S., Shirasawa, S., Nakayama, K. I., Nakanishi, M., Niida, H., & Kitagawa, M. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.88 · Cited by 28
Arumugam, T., Ghazi, T., & Chuturgoon, A. A. (2020) · Toxins · doi:10.3390/toxins12100625 · Cited by 27
Iwao, Y., Uchida, Y., Ueno, S., Yoshizaki, N., & Masui, Y. (2005) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2005.00802.x · Cited by 27
Cell Cycle Remodeling and Zygotic Gene Activation at the Midblastula Transition
Zhang, M., Skirkanich, J., Lampson, M. A., & Klein, P. S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-46095-6_9 · Cited by 23
Impact of DNA repair and stability defects on cortical development
Bianchi, F. T., Berto, G. E., & Cunto, F. D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2900-2 · Cited by 23
Libério, M. S., Sadowski, M. C., Davis, R. A., Rockstroh, A., Vasireddy, R. S., Lehman, M., & Nelson, C. C. (2015) · Oncotarget · doi:10.18632/oncotarget.6267 · Cited by 21
Ueno, S., Kono, R., & Iwao, Y. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.06.001 · Cited by 20
STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G2 Arrest in the Absence of DNA Damage
Kim, S.-O., Sakchaisri, K., Thimmegowda, N. R., Soung, N., Jang, J., Kim, Y. S., Lee, K. S., Kwon, Y. T., Asami, Y., Ahn, J. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053908 · Cited by 19
Small Molecule Inhibitors Targeting Key Proteins in the DNA Damage Response for Cancer Therapy
Li, L., Kumar, A. K., Hu, Z., & Guo, Z. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200224102309 · Cited by 17
Cryo-EM structure of the CDK2-cyclin A-CDC25A complex
Rowland, R. J., Korolchuk, S., Salamina, M., Tatum, N. J., Ault, J. R., Hart, S., Turkenburg, J. P., Blaza, J. N., Noble, M. E. M., & Endicott, J. (2024) · Nature Communications · doi:10.1038/s41467-024-51135-w · Cited by 14
Ćmielová, J., Havelek, R., Köhlerová, R., Soukup, T., Brůčková, L., Suchánek, J., Vávrová, J., Mokrý, J., & Řezáčová, M. (2013) · International Journal of Radiation Biology · doi:10.3109/09553002.2013.775530 · Cited by 14
Radiation-induced G2/M arrest rarely occurred in glioblastoma stem-like cells
Liu, J., Liu, Y., Xie, T., Luo, L., Xu, C., Gao, Q., Shen, L., Wan, F., Lei, T., & Ye, F. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1440094 · Cited by 14
Richardson, E., Stockwell, S. R., Li, H., Aherne, W., Cuomo, M. E., & Mittnacht, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031627 · Cited by 13
Varmeh, S., & Manfredi, J. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900037200 · Cited by 13
Amino Acids C-Terminal to the 14-3-3 Binding Motif in CDC25B Affect the Efficiency of 14-3-3 Binding
Uchida, S., Kubo, A., Kizu, R., Nakagama, H., Matsunaga, T., Ishizaka, Y., & Yamashita, K. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj079 · Cited by 14
Lee, C., Lee, H.-J., Kim, S., Nam, S.-B., Lee, G.-E., Yang, K. E., Lee, G. J., Chun, S. H., Kang, H. C., Lee, J. Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06647-0 · Cited by 13
Aberrant activation of cyclin A-CDK induces G2/M-phase checkpoint in human cells
Akaike, Y., & Chibazakura, T. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1693119 · Cited by 13
Bouché, J., Froment, C., Dozier, C., Esmenjaud, C., Lemaire, M., Monsarrat, B., Burlet‐Schiltz, O., & Ducommun, B. (2008) · Journal of Proteome Research · doi:10.1021/pr700623p · Cited by 13
FBXW7 -loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe
O’Brien, S., Ubhi, T., Wolf, L., Gandhi, K., Lin, S., Chaudary, N., Dhani, N. C., Milosevic, M., Brown, G. W., & Angers, S. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0306 · Cited by 13
Martin, J. C., Sims, J. R., Gupta, A. K., Bakin, A. V., & Ohm, J. E. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0130 · Cited by 12
Activation of both Mos and Cdc25 is required for G2‐M transition in perch oocyte
Priyadarshini, A., Basu, D., Kaidery, N. A., Bhattacharya, A., Bhattacharya, S., Maitra, S., & Bhattacharya, S. (2008) · Molecular Reproduction and Development · doi:10.1002/mrd.20952 · Cited by 11
Frazer, C., & Young, P. G. (2012) · Current Genetics · doi:10.1007/s00294-012-0379-1 · Cited by 11
Lee, S. F., Hirpara, J. L., Qu, J., Yadav, S. K., Sachaphibulkij, K., & Pervaiz, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.11.025 · Cited by 8
Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer—A Comprehensive Review of Literature
Kciuk, M., Wanke, K., Marciniak, B., Kołat, D., Aleksandrowicz, M., Mujwar, S., Ainane, T., & Kontek, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031152 · Cited by 7
Maintaining Genome Stability in Defiance of Mitotic DNA Damage
Ferrari, S. M., & Gentili, C. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00128 · Cited by 7
Regulation of Myt1 kinase activity via its N-terminal region in Xenopus meiosis and mitosis
Aiba, Y., Kim, J., Imamura, A., Okumoto, K., & Nakajo, N. (2021) · Cells and Development · doi:10.1016/j.cdev.2021.203754 · Cited by 5
Hornerin mediates phosphorylation of the polo-box domain in Plk1 by Chk1 to induce death in mitosis
Song, H., Kim, E. H., Hong, J., Gwon, D., Kim, J. W., Bae, G., & Jang, C. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01208-y · Cited by 6
Phosphorylation Mediated Regulation of Cdc25 Activity, Localization and Stability
Frazer, C., & Young, P. G. (2012) · InTech eBooks · doi:10.5772/48315 · Cited by 7
Tong, Y., Przytulinska, M., Tao, Z., Bouska, J. J., Stewart, K. D., Park, C., Li, G., Claiborne, A. K., Kovar, P. J., Chen, Z., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.069 · Cited by 5
Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance in Cancer Cells
Jalali-Zefrei, F., Mousavi, S. M., Delpasand, K., Shourmij, M., & Farzipour, S. (2024) · Current Gene Therapy · doi:10.2174/0115665232301727240422092311 · Cited by 4
Inhibition of Melanoma Cell Growth by Salvianolic Acid A through CHK2-CDC25A Pathway Modulation
Pu, X.-Y., Mei, Y., Zheng, Q., & Ko, C. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2906213 · Cited by 4
Chen, Z., Wang, C., Lei, C., Feng, X., Li, C., Jung, S. Y., Qin, J., & Chen, J. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00829 · Cited by 4
Sahay, O., Barik, G. K., Sharma, T., Pillai, A. D., Rapole, S., & Santra, M. K. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103261 · Cited by 4
Mechanism and regulation of secondary immunoglobulin diversification
Bello, A., Hirth, G., Voigt, S., Tepper, S., & Jungnickel, B. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2275397 · Cited by 3
Osorio-Zambrano, W. F., & Davey, S. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144434 · Cited by 3
Characterization of NimA-related Kinase 10 (NEK10): A Role in Checkpoint Control
Moniz, L. S. (2010) · TSpace (University of Toronto) · Cited by 3
Kim, S.-O., Sakchaisri, K., Thimmegowda, N. R., Soung, N., Jang, J., Kim, Y. S., Lee, K. S., Kwon, Y. T., Asami, Y., Ahn, J. S., et al. (2013) · PLoS ONE · doi:10.1371/annotation/c5f432f6-1e92-42c0-8727-7ae972215d6f · Cited by 3
Hu, L., Huang, W., Liu, B., & Eklund, E. A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107548 · Cited by 2
Environmental radiobiology of amphibians – knowledge gaps to be filled using cell lines
Vo, N. T. K. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1872815 · Cited by 2
Cdc25 Family Phosphatases in Cancer
Gabrielli, B. G., & Burgess, A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_11 · Cited by 2
Guo, Z., Wang, Y., Zhao, Y., Jin, Y., An, L., Xu, H. Y., Liu, Z., Chen, X., Zhou, H., Wang, H., et al. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29592 · Cited by 2
Cytofluorometric assessment of cell cycle progression in irradiated cells
Jiménez‐Cortegana, C., Klapp, V., Bloy, N., Galassi, C., Sato, A., Yamazaki, T., Buqué, A., Galluzzi, L., & Petroni, G. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2021.12.025 · Cited by 2
Infante, E., Terriac, E., Gélin, M., Siegfried, H., Pereira, D., Roca, V., Varet, H., Khalilian, S., Reinier, R., Asnacios, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.27.661506 · Cited by 2
Hussain, S., Mukherjee, N., & Gassman, N. R. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110876 · Cited by 1
Battista, B., Láscarez‐Lagunas, L. I., de Mendoza, D., & Colaiácovo, M. P. (2025) · Genetics · doi:10.1093/genetics/iyaf269 · Cited by 1
Vimentin Loss Inhibits DNA Damage Responses and Promotes Cancer Cell Survival.
Infante, E., Terriac, E., Gélin, M., Roca, V., Jabre, S., Siegfried, H., Pereira, D., Varet, H., Khalilian, S., Asnacios, A., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00913-2 · Cited by 1
Metadata
- Authors
- Uto, K., Inoue, D., Shimuta, K., Nakajo, N., & Sagata, N.
- Affiliations
- Kyushu University (JP)
- Corresponding author
- Sagata, Noriyuki
- ORCID
- Shimuta, Ken
- Venue
- The EMBO Journal
- Published
- 2004-07-22
- Volume
- 23
- Issue
- 16
- Pages
- 3386-3396
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC514503
- OpenAlex
- W2050348418
- Cited by
- 134
- References
- 47
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 5 · 2022: 4 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 10 · 2013: 9 · 2012: 6
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Science and Technology Agency (CREST)
- Core Research for Evolutional Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- Chk1, Chk2, CDC25A, Cdc25 phosphatase, cyclin-CDK complexes, CDK1/cyclin B, cyclin E/CDK2, DNA replication checkpoint, cell cycle arrest, 14-3-3 proteins, genotoxic stress, Xenopus embryo
- MeSH terms
- Checkpoint Kinase 1, Amino Acid Sequence, Animals, DNA Replication, Humans, Molecular Sequence Data, Mutation, Phosphorylation, Phosphothreonine, Protein Binding, Protein Kinases, Xenopus laevis, Cyclins, Sequence Alignment, Protein Serine-Threonine Kinases, cdc25 Phosphatases, Xenopus Proteins, 14-3-3 Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review